Kühnel G - Search Results

1

Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro.

Matzdorff AC, Berchner D, Kühnel G, Kemkes-Matthes B, Pralle H, Voss R. Matzdorff AC, et al. Among authors: kuhnel g. Haemostasis. 1998 Nov-Dec;28(6):277-88. doi: 10.1159/000022444. Haemostasis. 1998. PMID: 10461010

2

Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry.

Matzdorff AC, Kühnel G, Kemkes-Matthes B, Pralle H. Matzdorff AC, et al. Among authors: kuhnel g. J Lab Clin Med. 1998 Jun;131(6):507-17. doi: 10.1016/s0022-2143(98)90059-2. J Lab Clin Med. 1998. PMID: 9626986

3

Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.

Matzdorff AC, Kühnel G, Kemkes-Matthes B, Pralle H, Voss R, Fareed J. Matzdorff AC, et al. Among authors: kuhnel g. J Lab Clin Med. 2000 Mar;135(3):247-55. doi: 10.1067/mlc.2000.104907. J Lab Clin Med. 2000. PMID: 10711863

4

Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer.

Matzdorff AC, Kühnel G, Kemkes-Matthes B, Voss R. Matzdorff AC, et al. Among authors: kuhnel g. J Thromb Thrombolysis. 2001 Oct;12(2):129-39. doi: 10.1023/a:1012967320220. J Thromb Thrombolysis. 2001. PMID: 11729364

5

Protein Z influences the prothrombotic phenotype in Factor V Leiden patients.

Kemkes-Matthes B, Nees M, Kühnel G, Matzdorff A, Matthes KJ. Kemkes-Matthes B, et al. Among authors: kuhnel g. Thromb Res. 2002 May 15;106(4-5):183-5. doi: 10.1016/s0049-3848(02)00181-0. Thromb Res. 2002. PMID: 12297123

6

[1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET.

van den Hoff J, Burchert W, Börner AR, Fricke H, Kühnel G, Meyer GJ, Otto D, Weckesser E, Wolpers HG, Knapp WH. van den Hoff J, et al. Among authors: kuhnel g. J Nucl Med. 2001 Aug;42(8):1174-82. J Nucl Med. 2001. PMID: 11483676 Free article. Clinical Trial.

7

[Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography].

Weckesser E, Redeker J, Kühnel G, Börner AR, Flügel M, Knapp WH. Weckesser E, et al. Among authors: kuhnel g. Nuklearmedizin. 2000;39(3):N38-9. Nuklearmedizin. 2000. PMID: 10834199 German. No abstract available.

8

[The value of positron emission tomography (PET) in the treatment of patients with cancer of unknown primary (CUP)].

Rades D, Kühnel G, Wildfang I, Börner AR, Knapp W, Karstens JH. Rades D, et al. Among authors: kuhnel g. Strahlenther Onkol. 2001 Oct;177(10):525-9. doi: 10.1007/pl00002363. Strahlenther Onkol. 2001. PMID: 11680017 German.

9

Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management.

Rades D, Kühnel G, Wildfang I, Börner AR, Schmoll HJ, Knapp W. Rades D, et al. Among authors: kuhnel g. Ann Oncol. 2001 Nov;12(11):1605-9. doi: 10.1023/a:1013107732572. Ann Oncol. 2001. PMID: 11822762 Free article.

10

[18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings].

Kühnel G, Horn LC, Fischer U, Hesse S, Seese A, Georgi P, Kluge R. Kühnel G, et al. Zentralbl Gynakol. 2001 Apr;123(4):229-35. doi: 10.1055/s-2001-14780. Zentralbl Gynakol. 2001. PMID: 11370532 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters